Mydecine Health Sciences is a vertically integrated company developing novel fungtional© mushroom products and psychedelic medicines. Many current medicines and health products are being recognized as insufficient and Mydecine recognizes that there is an enormous opportunity to develop and commercialize new naturally-derived products in this area.
Based in Denver, Colorado and operating out of a 7,500 sq. ft. state of the art research centre, Mydecine's Health Sciences team is comprised of world-class mycologists, neuroscientists, psychopharmacologists, and geneticists. The team's focus is to discover the plethora of compounds in mushrooms which can benefit the brain and body, both in healthy and vulnerable populations, and to develop new psychedelic compounds that improve people's lives, especially those with mental health conditions.
Mydecine Health Sciences also has capabilities and infrastructure from Spore to Sale©, including the means to manufacture, package, and distribute these products throughout North America and at scale.